On November 11, Illumina rose 5.62% in Regular Trading, trading at $217.65 per share, with turnover of $30.552 million.
The move followed management commentary indicating high-single-digit revenue growth next year and an operating margin of at least 25.5% as a starting point, reinforcing expectations for a medium-term operating improvement.
That update builds on Illumina's latest quarterly results released on October 29, when adjusted EPS excluding tariff refunds was $1.44, above the $1.36 consensus, while revenue of $1.129 billion missed the $1.154 billion estimate. The company also raised full-year adjusted EPS guidance to $5.40-$5.45 from $5.30-$5.40 previously. Recent analyst actions were also supportive, including target increases to $250 from $215 and to $228 from $196 in the past two weeks.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments